Duran M, Willis J, Dalvi N, Fokakis Z, Virkus S, Hardaway J
Endocrinology. 2025; 166(3).
PMID: 39888375
PMC: 11850305.
DOI: 10.1210/endocr/bqaf019.
Krieger J, Daniels D, Lee S, Mastitskaya S, Langhans W
Compr Physiol. 2025; 15(1):e7.
PMID: 39887844
PMC: 11790259.
DOI: 10.1002/cph4.7.
Pradeloux S, Coulombe K, Ouamba A, Isenbrandt A, Calon F, Roy D
Nutrients. 2024; 16(19).
PMID: 39408276
PMC: 11478413.
DOI: 10.3390/nu16193309.
Chen Z, Deng X, Shi C, Jing H, Tian Y, Zhong J
J Clin Invest. 2024; 134(17).
PMID: 39225090
PMC: 11364389.
DOI: 10.1172/JCI178239.
Edvardsson C, Vestlund J, Ericson M, Jerlhag E
Front Pharmacol. 2024; 15:1439203.
PMID: 39221138
PMC: 11362053.
DOI: 10.3389/fphar.2024.1439203.
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism.
Hoffman S, Adeli K
Med Rev (2021). 2024; 4(4):301-311.
PMID: 39135603
PMC: 11317082.
DOI: 10.1515/mr-2024-0011.
Regulation of Energy and Glucose Homeostasis by the Nucleus of the Solitary Tract and the Area Postrema.
Bruce K, Garrido A, Zhang S, Lam T
Endocrinol Metab (Seoul). 2024; 39(4):559-568.
PMID: 39086274
PMC: 11377841.
DOI: 10.3803/EnM.2024.2025.
Dissociable hindbrain GLP1R circuits for satiety and aversion.
Huang K, Acosta A, Ghidewon M, McKnight A, Almeida M, Nyema N
Nature. 2024; 632(8025):585-593.
PMID: 38987598
DOI: 10.1038/s41586-024-07685-6.
Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the Treatment of Diabetes Mellitus.
Abiola J, Oluyemi A, Idowu O, Oyinloye O, Ubah C, Owolabi O
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931402
PMC: 11206448.
DOI: 10.3390/ph17060736.
Recent Research on Mechanisms of Feeding Regulation in Chicks.
Saneyasu T
J Poult Sci. 2024; 61:2024012.
PMID: 38681189
PMC: 11039390.
DOI: 10.2141/jpsa.2024012.
Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.
Herman R, Schmidt H
Physiol Behav. 2024; 281:114565.
PMID: 38663460
PMC: 11128349.
DOI: 10.1016/j.physbeh.2024.114565.
Glucagon-like peptide-1 receptor activation stimulates PKA-mediated phosphorylation of Raptor and this contributes to the weight loss effect of liraglutide.
Le T, Liu D, Besing G, Raghavan R, Ellis B, Ceddia R
Elife. 2023; 12.
PMID: 37930356
PMC: 10691799.
DOI: 10.7554/eLife.80944.
The locus coeruleus contributes to the anorectic, nausea, and autonomic physiological effects of glucagon-like peptide-1.
Fortin S, Chen J, Petticord M, Ragozzino F, Peters J, Hayes M
Sci Adv. 2023; 9(38):eadh0980.
PMID: 37729419
PMC: 10511187.
DOI: 10.1126/sciadv.adh0980.
Glucagon-like peptide-1 facilitates cerebellar parallel fiber glutamate release through PKA signaling in mice in vitro.
Wang X, Liu Y, Cao L, Li Y, Wan P, Qiu D
Sci Rep. 2023; 13(1):7948.
PMID: 37193712
PMC: 10188593.
DOI: 10.1038/s41598-023-34070-6.
GLP-1 enhances hyperpolarization-activated currents of mouse cerebellar Purkinje cell .
Liu Y, Cao L, Wang W, Piao Y, Wang J, Chu C
Front Mol Neurosci. 2023; 16:1126447.
PMID: 37089690
PMC: 10113493.
DOI: 10.3389/fnmol.2023.1126447.
Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the....
Olszanecka-Glinianowicz M, Mazur A, Chudek J, Kos-Kudla B, Markuszewski L, Dudek D
Nutrients. 2023; 15(7).
PMID: 37049479
PMC: 10097178.
DOI: 10.3390/nu15071641.
The role of glucagon-like peptide-1 (GLP-1) in fluid and food intakes in vasopressin-deficient Brattleboro rats.
Brakey D, Schatz K, Paul M, Daniels D
Physiol Behav. 2023; 262:114093.
PMID: 36706972
PMC: 9974868.
DOI: 10.1016/j.physbeh.2023.114093.
Evidence for Involvement of GIP and GLP-1 Receptors and the Gut-Gonadal Axis in Regulating Female Reproductive Function in Mice.
Khan D, Ojo O, Woodward O, Lewis J, Sridhar A, Gribble F
Biomolecules. 2022; 12(12).
PMID: 36551163
PMC: 9775379.
DOI: 10.3390/biom12121736.
Resetting the circadian clock of Alzheimer's mice GLP-1 injection combined with time-restricted feeding.
Dong Y, Cheng L, Zhao Y
Front Physiol. 2022; 13:911437.
PMID: 36148311
PMC: 9487156.
DOI: 10.3389/fphys.2022.911437.
Signaling pathways in obesity: mechanisms and therapeutic interventions.
Wen X, Zhang B, Wu B, Xiao H, Li Z, Li R
Signal Transduct Target Ther. 2022; 7(1):298.
PMID: 36031641
PMC: 9420733.
DOI: 10.1038/s41392-022-01149-x.